381 related articles for article (PubMed ID: 27856797)
1. Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors.
Ortiz DF; Lansing JC; Rutitzky L; Kurtagic E; Prod'homme T; Choudhury A; Washburn N; Bhatnagar N; Beneduce C; Holte K; Prenovitz R; Child M; Killough J; Tyler S; Brown J; Nguyen S; Schwab I; Hains M; Meccariello R; Markowitz L; Wang J; Zouaoui R; Simpson A; Schultes B; Capila I; Ling L; Nimmerjahn F; Manning AM; Bosques CJ
Sci Transl Med; 2016 Nov; 8(365):365ra158. PubMed ID: 27856797
[TBL] [Abstract][Full Text] [Related]
2. Engineered IgG1-Fc Molecules Define Valency Control of Cell Surface Fcγ Receptor Inhibition and Activation in Endosomes.
Bailey EM; Choudhury A; Vuppula H; Ortiz DF; Schaeck J; Manning AM; Bosques CJ; Hoppe AD
Front Immunol; 2020; 11():617767. PubMed ID: 33679705
[TBL] [Abstract][Full Text] [Related]
3. rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs.
Spirig R; Campbell IK; Koernig S; Chen CG; Lewis BJB; Butcher R; Muir I; Taylor S; Chia J; Leong D; Simmonds J; Scotney P; Schmidt P; Fabri L; Hofmann A; Jordi M; Spycher MO; Cattepoel S; Brasseit J; Panousis C; Rowe T; Branch DR; Baz Morelli A; Käsermann F; Zuercher AW
J Immunol; 2018 Apr; 200(8):2542-2553. PubMed ID: 29531170
[TBL] [Abstract][Full Text] [Related]
4. The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases.
Karsten CM; Köhl J
Immunobiology; 2012 Nov; 217(11):1067-79. PubMed ID: 22964232
[TBL] [Abstract][Full Text] [Related]
5. Monovalent Fc receptor blockade by an anti-Fcγ receptor/albumin fusion protein ameliorates murine ITP with abrogated toxicity.
Yu X; Menard M; Prechl J; Bhakta V; Sheffield WP; Lazarus AH
Blood; 2016 Jan; 127(1):132-8. PubMed ID: 26500340
[TBL] [Abstract][Full Text] [Related]
6. The Dual Targeting of FcRn and FcγRs
Monnet C; Jacque E; de Romeuf C; Fontayne A; Abache T; Fournier N; Dupont G; Derache D; Engrand A; Bauduin A; Terrier A; Seifert A; Beghin C; Longue A; Masiello N; Danino L; Nogre M; Raia A; Dhainaut F; Fauconnier L; Togbe D; Reitinger C; Nimmerjahn F; Stevens W; Chtourou S; Mondon P
Front Immunol; 2021; 12():728322. PubMed ID: 34512662
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs.
Mimoto F; Kadono S; Katada H; Igawa T; Kamikawa T; Hattori K
Mol Immunol; 2014 Mar; 58(1):132-8. PubMed ID: 24334029
[TBL] [Abstract][Full Text] [Related]
8. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
[TBL] [Abstract][Full Text] [Related]
9. An Engineered Human Fc variant With Exquisite Selectivity for FcγRIIIa
Kang TH; Lee CH; Delidakis G; Jung J; Richard-Le Goff O; Lee J; Kim JE; Charab W; Bruhns P; Georgiou G
Front Immunol; 2019; 10():562. PubMed ID: 30984171
[TBL] [Abstract][Full Text] [Related]
10. Dissecting FcγR Regulation through a Multivalent Binding Model.
Robinett RA; Guan N; Lux A; Biburger M; Nimmerjahn F; Meyer AS
Cell Syst; 2018 Jul; 7(1):41-48.e5. PubMed ID: 29960887
[TBL] [Abstract][Full Text] [Related]
11. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
[TBL] [Abstract][Full Text] [Related]
12. Extravasations and emigration of neutrophils to the inflammatory site depend on the interaction of immune-complex with Fcgamma receptors and can be effectively blocked by decoy Fcgamma receptors.
Shashidharamurthy R; Hennigar RA; Fuchs S; Palaniswami P; Sherman M; Selvaraj P
Blood; 2008 Jan; 111(2):894-904. PubMed ID: 17962513
[TBL] [Abstract][Full Text] [Related]
13. Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo.
Biburger M; Aschermann S; Schwab I; Lux A; Albert H; Danzer H; Woigk M; Dudziak D; Nimmerjahn F
Immunity; 2011 Dec; 35(6):932-44. PubMed ID: 22169040
[TBL] [Abstract][Full Text] [Related]
14. IgG Fc variant cross-reactivity between human and rhesus macaque FcγRs.
Boesch AW; Miles AR; Chan YN; Osei-Owusu NY; Ackerman ME
MAbs; 2017 Apr; 9(3):455-465. PubMed ID: 28055295
[TBL] [Abstract][Full Text] [Related]
15. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
[TBL] [Abstract][Full Text] [Related]
16. The FcγR/IgG Interaction as Target for the Treatment of Autoimmune Diseases.
Sondermann P
J Clin Immunol; 2016 May; 36 Suppl 1():95-9. PubMed ID: 27039179
[TBL] [Abstract][Full Text] [Related]
17. Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes.
Fox JM; Roy V; Gunn BM; Huang L; Edeling MA; Mack M; Fremont DH; Doranz BJ; Johnson S; Alter G; Diamond MS
Sci Immunol; 2019 Feb; 4(32):. PubMed ID: 30796092
[TBL] [Abstract][Full Text] [Related]
18. Divergent Requirement of Fc-Fcγ Receptor Interactions for
Wang S; Ren H; Jiang W; Chen H; Hu H; Chen Z; Zhou P
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331095
[TBL] [Abstract][Full Text] [Related]
19. STIM1 is essential for Fcgamma receptor activation and autoimmune inflammation.
Braun A; Gessner JE; Varga-Szabo D; Syed SN; Konrad S; Stegner D; Vögtle T; Schmidt RE; Nieswandt B
Blood; 2009 Jan; 113(5):1097-104. PubMed ID: 18941110
[TBL] [Abstract][Full Text] [Related]
20. A Cell-Based Reporter Assay Measuring the Activation of Fc Gamma Receptors Induced by Therapeutic Monoclonal Antibodies.
Aoyama M; Tada M; Ishii-Watabe A
Methods Mol Biol; 2019; 1904():423-429. PubMed ID: 30539484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
